Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

  1. Mayer, E.L.
  2. Dueck, A.C.
  3. Martin, M.
  4. Rubovszky, G.
  5. Burstein, H.J.
  6. Bellet-Ezquerra, M.
  7. Miller, K.D.
  8. Zdenkowski, N.
  9. Winer, E.P.
  10. Pfeiler, G.
  11. Goetz, M.
  12. Ruiz-Borrego, M.
  13. Anderson, D.
  14. Nowecki, Z.
  15. Loibl, S.
  16. Moulder, S.
  17. Ring, A.
  18. Fitzal, F.
  19. Traina, T.
  20. Chan, A.
  21. Rugo, H.S.
  22. Lemieux, J.
  23. Henao, F.
  24. Lyss, A.
  25. Antolin Novoa, S.
  26. Wolff, A.C.
  27. Vetter, M.
  28. Egle, D.
  29. Morris, P.G.
  30. Mamounas, E.P.
  31. Gil-Gil, M.J.
  32. Prat, A.
  33. Fohler, H.
  34. Metzger Filho, O.
  35. Schwarz, M.
  36. DuFrane, C.
  37. Fumagalli, D.
  38. Theall, K.P.
  39. Lu, D.R.
  40. Bartlett, C.H.
  41. Koehler, M.
  42. Fesl, C.
  43. DeMichele, A.
  44. Gnant, M.
  45. Show all authors +
Journal:
The Lancet Oncology

ISSN: 1474-5488 1470-2045

Year of publication: 2021

Volume: 22

Issue: 2

Pages: 212-222

Type: Article

DOI: 10.1016/S1470-2045(20)30642-2 GOOGLE SCHOLAR